{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06407973",
            "orgStudyIdInfo": {
                "id": "09074"
            },
            "organization": {
                "fullName": "Sight Sciences, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Pseudophakic Eyes",
            "officialTitle": "A Randomized Clinical Trial of ab Interno Canaloplasty and Trabeculotomy With the OMNI Surgical System Compared to Standard Medical Treatment in Pseudophakic Patients With Primary Open Angle Glaucoma",
            "acronym": "EVOLVE",
            "therapeuticArea": [
                "Ophthalmology"
            ],
            "study": "a-clinical-trial-comparing-the-omni-surgical-system-to-standard-medical-treatment-in-pseudophakic-eyes"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-06-30",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-05-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-05-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-05-06",
            "studyFirstSubmitQcDate": "2024-05-06",
            "studyFirstPostDateStruct": {
                "date": "2024-05-09",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-21",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Sight Sciences, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": true,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "A Randomized Clinical Trial of Ab Interno Canaloplasty and Trabeculotomy with the OMNI\u00ae Surgical System Compared to Standard Medical Treatment in Pseudophakic Patients with Primary Open Angle Glaucoma (EVOLVE)",
            "detailedDescription": "This prospective, multicenter, post-market clinical trial will evaluate the safety and effectiveness of canaloplasty and trabeculotomy using the OSS in pseudophakic patients with POAG with DIOP \u2265 20 mmHg on prostaglandin monotherapy."
        },
        "conditionsModule": {
            "conditions": [
                "Primary Open Angle Glaucoma"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Randomized controlled open label",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 334,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Surgical (OMNI Surgical System (OSS))",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Canaloplasty followed by Trabeculotomy using the OMNI Surgical System.",
                    "interventionNames": [
                        "Device: OMNI Surgical System"
                    ]
                },
                {
                    "label": "Standard Medical Care (SMC)",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Standard Medical Care with Latanoprost and an adjunctive glaucoma medication at the discretion of the Principal Investigator",
                    "interventionNames": [
                        "Drug: Latanoprost plus adjunctive glaucoma medication"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "OMNI Surgical System",
                    "description": "The OMNI Surgical System is 510(k) cleared and indicated for canaloplasty (microcatheterization and transluminal viscodilation of Schlemm's canal) followed by trabeculotomy (cutting of trabecular meshwork) to reduce intraocular pressure in adult patients with primary open-angle glaucoma",
                    "armGroupLabels": [
                        "Surgical (OMNI Surgical System (OSS))"
                    ],
                    "otherNames": [
                        "OMNI"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Latanoprost plus adjunctive glaucoma medication",
                    "description": "* Latanoprost ophthalmic solution (0.005%) is a topical prostaglandin F2 analog used in the treatment of Glaucoma.\n* An adjunctive topical glaucoma medication of a different class as selected by the Investigator",
                    "armGroupLabels": [
                        "Standard Medical Care (SMC)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Subjects with a \u2265 20% reduction",
                    "description": "Proportion of subjects with a \u2265 20% reduction from medicated baseline in mean diurnal IOP (DIOP) at 12 months post-operatively",
                    "timeFrame": "12 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Diurnal IOP (DIOP) between 6 and 18 mmHg (inclusive)",
                    "description": "Proportion of eyes at 12 months post-randomization, with mean medicated diurnal IOP (DIOP) between 6 and 18 mmHg (inclusive).",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Number of Ocular Hypotensive Medications",
                    "description": "Mean number of ocular hypotensive medications used at 12 months",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Tear break-up time (TBUT)",
                    "description": "Proportion of eyes with a minimal clinically important difference (MCID) defined as a 1 category improvement, in tear beak-up time (TBUT)",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Corneal or conjunctival staining",
                    "description": "Proportion of eyes with improvement in corneal staining or conjunctival staining by at least one category with no worsening in either at 12 months compared to baseline.",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "OSDI score",
                    "description": "Proportion of subjects with a MCID in ocular surface disease index (OSDI) score at 12 months compared to baseline",
                    "timeFrame": "12 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Male or female subjects, 45 years or older.\n2. History of uncomplicated cataract surgery and posterior chamber intraocular lens (IOL) implantation without compromise to the lens capsule, zonular dehiscence/rupture or vitreous prolapse, 6 months or more prior to Baseline Visit.\n3. Under treatment with a topical prostaglandin F2 analog (e.g. latanoprost, travoprost, bimatoprost, tafluprost) as monotherapy for a minimum of 3 months prior to the Screening visit.\n4. Intraocular pressure (IOP) at the Screening visit of 20 mmHg or more and not exceeding 36 mmHg.\n5. Diagnosed with primary open angle glaucoma (POAG).\n\nExclusion Criteria:\n\n1. Any of the following prior ocular procedures:\n\n   * Laser trabeculoplasty \u2264180 days prior to baseline\n   * Durysta \u226412 months prior to baseline\n   * Implanted with iStent (All types), Cypass, Xen, Express, glaucoma draining device/valve, or Hydrus Device; or\n   * Prior canaloplasty, goniotomy, trabeculotomy, trabeculectomy, endoscopiccyclophotocoagulation (ECP), Cyclophotocoagulation or CPC (G probe)\n   * Retinal laser procedure \u22643 months prior to baseline\n2. Concurrent IOP-lowering procedure other than the study procedure (OSS) (e.g. ECP, CPC,etc.)\n3. Forms of glaucoma other than POAG including but not limited to: Pigmentary, pseudoexfoliative, acute angle closure, normal tension, pre-perimetric, traumatic, congenital, malignant, uveitic, neovascular or severe glaucoma as documented in subject's medical record.\n4. Women of childbearing potential if they are currently pregnant or intend to become pregnant during the study period; are breast-feeding; or are not in agreement to use adequate birth control methods to prevent pregnancy throughout the study",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "45 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Jaime Dickerson, PhD",
                    "role": "CONTACT",
                    "phone": "+1 (817) 845-0859",
                    "email": "jdickerson@sightsciences.com"
                },
                {
                    "name": "Afua Ohene-Nyako, MS",
                    "role": "CONTACT",
                    "phone": "+1 (408)427-7596",
                    "email": "AOheneNyako@sightsciences.com"
                }
            ],
            "locations": [
                {
                    "facility": "North Bay Eye Associates",
                    "city": "Petaluma",
                    "state": "California",
                    "zip": "94954",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.23242,
                        "lon": -122.63665
                    }
                },
                {
                    "facility": "University Eye Specialists",
                    "city": "Maryville",
                    "state": "Tennessee",
                    "zip": "37803",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kenneth Olander, MD/PhD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.75647,
                        "lon": -83.97046
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005901",
                    "term": "Glaucoma"
                },
                {
                    "id": "D000005902",
                    "term": "Glaucoma, Open-Angle"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009798",
                    "term": "Ocular Hypertension"
                },
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9013",
                    "name": "Glaucoma",
                    "asFound": "Glaucoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9014",
                    "name": "Glaucoma, Open-Angle",
                    "asFound": "Primary Open Angle Glaucoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10024",
                    "name": "Hypertension",
                    "relevance": "LOW"
                },
                {
                    "id": "M12731",
                    "name": "Ocular Hypertension",
                    "relevance": "LOW"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000077338",
                    "term": "Latanoprost"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009883",
                    "term": "Ophthalmic Solutions"
                },
                {
                    "id": "D000019999",
                    "term": "Pharmaceutical Solutions"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M12814",
                    "name": "Ophthalmic Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M1775",
                    "name": "Latanoprost",
                    "asFound": "Basal",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17941",
                    "name": "Dinoprost",
                    "relevance": "LOW"
                },
                {
                    "id": "M223476",
                    "name": "Dinoprost tromethamine",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Repr",
                    "name": "Reproductive Control Agents"
                }
            ]
        }
    },
    "hasResults": false
}